PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportssoft tissue infections
MeSH D018461 - soft tissue infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D007239:Infections
$
Success rate
D018461: 
Soft tissue infections
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaAmoxicillin Amoxicillin  1982-01-01   
Amoxicillin, Clavulanic acid Amoxicillin Clavulanate Potassium  2004-05-25   
Ampicillin Ampicillin Trihydrate  1982-01-01   
Cefadroxil Cefadroxil  1989-02-10   
Cefazolin Cefazolin  1989-03-14   
Ceftriaxone Ceftriaxone  2007-03-15   
Cephalexin Cephalexin  1982-01-01   
Levofloxacin Levofloxacin  2011-06-20   
Linezolid Linezolid  2015-05-18   
Ofloxacin Ofloxacin  2003-09-02   
PadagisHydrocortisone, Bacitracin, Neomycin, Polymyxin b Bacitracin-neomycin-polymyxin W/ Hydrocortisone  1982-01-01   
Dexamethasone, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Dexamethasone  1989-07-31   
Glenmark PharmaceuticalsLevofloxacin Levofloxacin  2011-06-20   
Linezolid Linezolid  2015-12-21   
MylanAmoxicillin Amoxicillin  1982-01-01   
Ampicillin Ampicillin Trihydrate  1982-01-01   
Levofloxacin Levofloxacin  2011-06-20   
Linezolid Linezolid  2017-12-06   
NATCO PharmaLevofloxacin Levofloxacin  2011-06-20   
Johnson & JohnsonOfloxacin Floxin  1990-12-28   
Levofloxacin Levaquin  1996-12-20   
GSKAmoxicillin Amoxil  1982-01-01   
Cefazolin Ancef  1982-01-01   
Cefazolin Cefazolin  1993-10-31   
Ceftazidime Ceptaz  1990-09-27   
Amoxicillin Larotid  1982-01-01   
Ceftazidime Pentacef  1995-11-07   
Ticarcillin, Clavulanic acid Timentin  1986-12-19   
Ampicillin Totacillin  1982-01-01   
Ampicillin Totacillin-n  1982-01-01   
RocheCeftriaxone, Lidocaine Rocephin  1985-03-12 $261.076 M Y2021 
Lupin ResearchCefadroxil Cefadroxil  2007-05-29   
Ceftriaxone Ceftriaxone  2003-09-30   
Cephalexin Cephalexin  2005-11-25   
Levofloxacin Levofloxacin  2011-06-20   
1
2
3
4
5
6
...
14
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
40%
2/5
Phase 3
87%
47/54
Approved: 44Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Johnson & Johnson
1
2
3
4
5
6
...
10
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use